LGALS3 and carcinoma: Galectin-3 protein expression in the cytoplasm and nucleus was mainly seen in the malignant FPTLs (FVPTC).It was focally seen in 3/51 cases of benign lesions (7.9% of HNs and 0.0 % of FA), in 3/12 (25 %) NIFTP, and in 15/20 carcinomas (52.9% FVPTC and 0.0% of FC).